Elevation Oncology Inc reports results for the quarter ended in June - Earnings Summary

Elevation Oncology

12/08/2021 22:35

* Elevation Oncology Inc  ELEV.OQ  reported a quarterly adjusted
loss of $4.84​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of $2.82 per share.
* Reported revenue was zero​;  analysts expected zero. 
* Elevation Oncology Inc's reported EPS for the quarter was a
loss of $4.84​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Elevation Oncology Inc shares had fallen by 21.2% this
quarter.
* The company reported a quarterly loss of $5.06 million.
* Wall Street's median 12-month price target for Elevation
Oncology Inc is $23.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 09:35 p.m.  ​All
figures in US dollars unless otherwise stated